We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.28%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.78B
AUM Growth
+$1.86B
Cap. Flow
+$1.52B
Cap. Flow %
26.37%
Top 10 Hldgs %
27.07%
Holding
7,146
New
1,119
Increased
2,707
Reduced
2,319
Closed
676

Sector Composition

Rank Sector Weight
1 Technology 25.28%
2 Consumer Discretionary 10.53%
3 Financials 9.98%
4 Healthcare 8.97%
5 Communication Services 8.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RWT
4101
Redwood Trust
RWT
$604M
$14K ﹤0.01%
1,060
-899
-46% -$12.2K
SCS
4102
DELISTED
Steelcase
SCS
$14K ﹤0.01%
1,246
-4,997
-80% -$60.2K
SCSC icon
4103
Scansource
SCSC
$1.08B
$14K ﹤0.01%
408
-390
-49% -$13.7K
SSBI icon
4104
Summit State Bank
SSBI
$87.4M
$14K ﹤0.01%
908
+866
+2,062% +$14.2K
TARS icon
4105
Tarsus Pharmaceuticals
TARS
$3.04B
$14K ﹤0.01%
652
+187
+40% +$4.86K
TCRT icon
4106
Alaunos Therapeutics
TCRT
$4.71M
$14K ﹤0.01%
83
-17
-17% -$3.74K
TIGR
4107
UP Fintech Holding
TIGR
$822M
$14K ﹤0.01%
2,846
-5,600
-66% -$39.2K
TMCI icon
4108
Treace Medical Concepts
TMCI
$312M
$14K ﹤0.01%
746
+413
+124% +$8.52K
TSHA icon
4109
Taysha Gene Therapies
TSHA
$1.94B
$14K ﹤0.01%
1,180
+390
+49% +$5.88K
TYRA icon
4110
Tyra Biosciences
TYRA
$1.51B
$14K ﹤0.01%
+963
New +$19.1K
UONE icon
4111
Urban One Class A
UONE
$23.3M
$14K ﹤0.01%
302
-2,060
-87% -$139K
UPLD icon
4112
Upland Software
UPLD
$15.7M
$14K ﹤0.01%
79
-71
-47% -$18.1K
USLM icon
4113
United States Lime & Minerals
USLM
$3.37B
$14K ﹤0.01%
550
+140
+34% +$3.5K
USNA icon
4114
Usana Health Sciences
USNA
$247M
$14K ﹤0.01%
137
-599
-81% -$59.8K
VERA icon
4115
Vera Therapeutics
VERA
$2.28B
$14K ﹤0.01%
538
-67
-11% -$1.48K
VITL icon
4116
Vital Farms
VITL
$468M
$14K ﹤0.01%
761
-427
-36% -$7.54K
VYM icon
4117
Vanguard High Dividend Yield ETF
VYM
$84B
$14K ﹤0.01%
126
-21,792
-99% -$2.37M
WKC icon
4118
World Kinect Corp
WKC
$1.85B
$14K ﹤0.01%
544
-9,190
-94% -$262K
WLDN icon
4119
Willdan Group
WLDN
$1.32B
$14K ﹤0.01%
396
-64
-14% -$2.38K
XBIT icon
4120
XBiotech
XBIT
$70.1M
$14K ﹤0.01%
1,251
+451
+56% +$5.87K
XMTR icon
4121
Xometry
XMTR
$5.52B
$14K ﹤0.01%
267
+83
+45% +$4.27K
YALA
4122
Yalla Group
YALA
$832M
$14K ﹤0.01%
2,128
-996
-32% -$7.06K
NPKI
4123
NPK International
NPKI
$1.21B
$14K ﹤0.01%
4,674
-546
-10% -$1.75K
HTB
4124
HomeTrust Bancshares
HTB
$834M
$14K ﹤0.01%
448
-117
-21% -$3.55K
HA
4125
DELISTED
Hawaiian Holdings, Inc.
HA
$14K ﹤0.01%
757
-3,054
-80% -$61.9K

Similar funds

Tower Research Capital (TRC)'s Q4 2021 Portfolio in Review

As of Q4 2021, Tower Research Capital (TRC) held 7,146 positions worth $5.78B, up 48% from $3.92B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $1.52B of net new capital in Q4 2021, opening 1,119 new positions and adding to 2,707 existing holdings. Its largest new stake was iShares Russell 1000 ETF: 47,514 shares worth $12.6M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $404M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2021 buy was iShares Russell 1000 ETF: 47,514 shares worth $12.6M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2021, an estimated $125M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $404M.
  • Tower Research Capital (TRC) fully exited State Street SPDR S&P MIDCAP 400 ETF Trust in Q4 2021, selling an estimated $36.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $5.78B portfolio in Q4 2021.
  • Tower Research Capital (TRC) opened 1,119 new positions and closed 676 in Q4 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $5.78B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2021, filed 14 Feb 2022.